• Inventors:
  • Assignees:
  • Publication Date: December 31, 1969
  • Publication Number:

Abstract

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (32)

    Publication numberPublication dateAssigneeTitle
    CN-102630162-AAugust 08, 2012雷普特医疗公司4-methylpyrazole formulations
    CN-102630162-BJuly 09, 2014雷普特医疗公司4-甲基吡唑制剂
    US-2003073713-A1April 17, 2003Schoenhard Grant L.Inhibitors of ABC drug transporters at the blood-brain barrier
    US-2005266072-A1December 01, 2005Euro-Celtique S.A.Pharmaceutical compositions
    US-2006039970-A1February 23, 2006Benjamin Oshlack, Curtis Wright, Haddox J DTamper-resistant oral opioid agonist formulations
    US-2006148978-A1July 06, 2006Reneker Darrell H, Chase George C, Smith Daniel J, Sphurti DoiphodePolymer structures formed on fibers and/or nanofiber
    US-2008305167-A2December 11, 2008Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-2011053999-A1March 03, 2011Daley Thomas E, Squiers Elizabeth C, Kin-Hung Peony Yu4-methylpyrazole formulations for inhibiting ethanol intolerance
    US-2013101535-A1April 25, 2013Board Of Regents, The University Of Texas System, The Regents Of The University Of CaliforniaAldehyde dehydrogenase inhibitors as novel depigmenting agents
    US-7034036-B2April 25, 2006Pain Therapeutics, Inc.Inhibitors of ABC drug transporters at the blood-brain barrier
    US-7658939-B2February 09, 2010Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-7682632-B2March 23, 2010Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-7718192-B2May 18, 2010Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-7842309-B2November 30, 2010Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-7842311-B2November 30, 2010Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-7914818-B2March 29, 2011Purdue Pharma L.P.Opioid agonist formulations with releasable and sequestered antagonist
    US-7943173-B2May 17, 2011Purdue Pharma L.P.Pharmaceutical combinations of oxycodone and naloxone
    US-8231901-B2July 31, 2012Purdue Pharma L.P.Opioid agonist formulations with releasable and sequestered antagonist
    US-8236351-B2August 07, 2012Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-8357399-B2January 22, 2013Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-8518443-B2August 27, 2013Purdue Pharma, L.P.Opioid agonist formulations with releasable and sequestered antagonist
    US-8586088-B2November 19, 2013Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-8802733-B2August 12, 2014The Regents Of The University Of California, Board Of Regents, The University Of Texas SystemAldehyde dehydrogenase inhibitors as novel depigmenting agents
    US-8815287-B2August 26, 2014Purdue Pharma L.P.Opiod agonist formulations with releasable and sequestered antagonist
    US-8936812-B2January 20, 2015Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-9149436-B2October 06, 2015Purdue Pharma L.P.Pharmaceutical product comprising a sequestered agent
    US-9173850-B2November 03, 2015Raptor Pharmaceuticals Inc.4-methylpyrazole formulations
    US-9278073-B2March 08, 2016Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-9326971-B2May 03, 2016Raptor Pharmaceuticals Inc.4-methylpyrazole formulations for inhibiting ethanol intolerance
    US-9456989-B2October 04, 2016Purdue Pharma L.P.Tamper-resistant oral opioid agonist formulations
    US-9801828-B2October 31, 2017Purdue Pharma L.P.Tamper resistant oral opioid agonist formulations
    WO-2011071805-A1June 16, 2011Raptor Pharmaceuticals Inc.4-methylpyrazole formulations